Donepezil- and scopolamine-induced rCMRglu changes assessed by PET in conscious rhesus monkeys

Annals of Nuclear Medicine

Volumn 23, Issue 10, 2009, Pages 877-882

  Asai, Makoto ^a,b   Fujikawa, Akihiko ^a,b   Noda, Akihiro ^a,b   Miyoshi, Sosuke ^a,b   Matsuoka, Nobuya ^b   Nishimura, Shintaro ^a,b  

^a Medical and Pharmacological Research Center Foundation   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

Donepezil; FDG PET; Muscarinic ACh receptor; Rhesus monkey; Scopolamine

Indexed keywords

DONEPEZIL; FLUORODEOXYGLUCOSE F 18; GLUCOSE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; CEREBELLUM; CONSCIOUSNESS; CONTROLLED STUDY; GLUCOSE METABOLISM; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHESUS MONKEY; THALAMUS;

ANIMALS; BRAIN; CHOLINESTERASE INHIBITORS; CONSCIOUSNESS; DRUG COMBINATIONS; FLUORODEOXYGLUCOSE F18; GLUCOSE; INDANS; MACACA MULATTA; MALE; PIPERIDINES; POSITRON-EMISSION TOMOGRAPHY; SCOPOLAMINE;

EID: 72949089704     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-009-0316-7     Document Type: Article

References (25)

1. A Drzezga N Lautenschlager H Siebner M Riemenschneider F Willoch S Minoshima, et al. 2003 Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study Eur J Nucl Med Mol Imaging 30 8 1104 1113 10.1007/s00259-003-1194-1 12764551 (Pubitemid 36988222)
2. A Drzezga T Grimmer M Riemenschneider N Lautenschlager H Siebner P Alexopoulus, et al. 2005 Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET J Nucl Med 46 10 1625 1632 1:CAS:528:DC%2BD28XitVGltrc%3D 16204712
3. DG Wilkinson PT Francis E Schwam J Payne-Parrish 2004 Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy Drugs Aging 21 7 453 478 10.2165/00002512-200421070-00004 1:CAS:528:DC%2BD2cXlsVCmurg%3D 15132713 (Pubitemid 38736890)
4. PJ Modrego 2006 The effect of drugs for Alzheimer disease assessed by means of neuroradiological techniques Curr Med Chem 13 28 3417 3424 10.2174/092986706779010289 1:CAS:528:DC%2BD28XhtFyrtrzE 17168714 (Pubitemid 44873753)
5. SJ Teipel A Drzezga P Bartenstein HJ Moller M Schwaiger H Hampel 2006 Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial Psychopharmacology (Berl) 187 1 86 94 10.1007/s00213-006-0408-1 1:CAS:528:DC%2BD28XlsV2ktbw%3D (Pubitemid 43876920)
6. E Stefanova A Wall O Almkvist A Nilsson A Forsberg B Langstrom, et al. 2006 Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease J Neural Transm 113 2 205 218 10.1007/s00702-005-0312-6 1:STN:280:DC%2BD28%2FjtlGjsQ%3D%3D 16049637 (Pubitemid 43121756)
7. MS Mega ID Dinov V Porter G Chow E Reback P Davoodi, et al. 2005 Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study Arch Neurol 62 5 721 728 10.1001/archneur.62.5.721 15883258 (Pubitemid 40656086)
8. N De-Mello IQ Souza-Junior AP Carobrez 2005 Pilocarpine prevents age-related spatial learning impairments in rats Behav Brain Res 158 2 263 268 10.1016/j.bbr.2004.09.006 1:CAS:528:DC%2BD2MXhtFOntL0%3D 15698892 (Pubitemid 40208472)
9. CM Hernandez DA Gearhart V Parikh EJ Hohnadel LW Davis ML Middlemore, et al. 2006 Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats J Pharmacol Exp Ther 316 2 679 694 10.1124/jpet.105.093047 1:CAS:528:DC%2BD28XhtlWqsbk%3D 16214877 (Pubitemid 43130995)
10. RD Prediger N De-Mello RN Takahashi 2006 Pilocarpine improves olfactory discrimination and social recognition memory deficits in 24 month-old rats Eur J Pharmacol 531 1-3 176 182 10.1016/j.ejphar.2005.12.032 1:CAS:528: DC%2BD28XhtlejtL4%3D 16438956 (Pubitemid 43202232)
11. A Green KA Ellis J Ellis CF Bartholomeusz S Ilic RJ Croft, et al. 2005 Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans Pharmacol Biochem Behav 81 3 575 584 10.1016/j.pbb.2005.04.010 1:CAS:528:DC%2BD2MXmt1artro%3D 15936063 (Pubitemid 40966805)
12. JJ Buccafusco AV Terry Jr MW Decker M Gopalakrishnan 2007 Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys Biochem Pharmacol 74 8 1202 1211 10.1016/j.bcp.2007.07.010 1:CAS:528: DC%2BD2sXhtVOgu7nI 17706609 (Pubitemid 47417930)
13. H Onoe O Inoue K Suzuki H Tsukada T Itoh N Mataga, et al. 1994 Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey Brain Res 663 2 191 198 10.1016/0006-8993(94)91263-7 1:CAS:528:DyaK2MXhvFeqtLs%3D 7874501 (Pubitemid 24339032)
14. NM Rupniak SJ Tye MJ Field 1997 Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys Psychopharmacology (Berl) 131 4 406 410 10.1007/s002130050310 1:CAS:528:DyaK2sXktF2lu7Y%3D (Pubitemid 27348708)
15. M Watanabe H Okada K Shimizu T Omura E Yoshikawa T Kosugi, et al. 1997 A high resolution animal PET scanner using compact PS-PMT detectors IEEE Trans Nucl Sci 44 1277 1282 10.1109/23.597001 1:CAS:528:DyaK2sXksVGgsrw%3D
16. L Sokoloff M Reivich C Kennedy MH Des Rosiers CS Patlak KD Pettigrew, et al. 1977 The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat J Neurochem 28 5 897 916 10.1111/j.1471-4159.1977. tb10649.x 1:CAS:528:DyaE2sXltlWiuro%3D 864466
17. ME Phelps SC Huang EJ Hoffman C Selin L Sokoloff DE Kuhl 1979 Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-d-glucose: validation of method Ann Neurol 6 5 371 388 10.1002/ana.410060502 1:CAS:528:DyaL3cXlsVGrtA%3D%3D 117743 (Pubitemid 10203423)
18. M Reivich A Alavi A Wolf J Fowler J Russell C Arnett, et al. 1985 Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose J Cereb Blood Flow Metab 5 2 179 192 1:STN:280:DyaL2M7ot12jsw%3D%3D 3988820
19. DJ Cross S Minoshima S Nishimura A Noda H Tsukada DE Kuhl 2000 Three-dimensional stereotactic surface projection analysis of macaque brain PET: development and initial applications J Nucl Med 41 11 1879 1887 1:STN:280:DC%2BD3M%2FktFOksg%3D%3D 11079499
20. J Blin CA Ray MF Piercey JJ Bartko MM Mouradian TN Chase 1994 Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography Brain Res 635 1-2 196 202 10.1016/0006-8993(94)91439-7 1:CAS:528:DyaK2cXht1Cltb8%3D 8173955
21. K Mishima K Iwasaki H Tsukikawa Y Matsumoto N Egashira K Abe, et al. 2000 The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats Jpn J Pharmacol 84 2 163 173 10.1254/jjp.84.163 1:CAS:528:DC%2BD3cXnvVGgtrg%3D 11128039 (Pubitemid 30833885)
22. MG Vannucchi C Scali SR Kopf G Pepeu F Casamenti 1997 Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats Neuroscience 79 3 837 846 10.1016/S0306-4522(97)00091-2 1:CAS:528:DyaK2sXktlWntLw%3D 9219946 (Pubitemid 27292679)
23. RW Jones H Soininen K Hager D Aarsland P Passmore A Murthy, et al. 2004 A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease Int J Geriatr Psychiatry 19 1 58 67 10.1002/gps.1038 14716700 (Pubitemid 38180693)
24. A Kadir T Darreh-Shori O Almkvist A Wall M Grut B Strandberg, et al. 2008 PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD Neurobiol Aging 29 8 1204 1217 10.1016/j.neurobiolaging.2007.02.020 1:CAS:528:DC%2BD1cXnsF2lsbY%3D 17379359 (Pubitemid 351822413)
25. DE Kuhl S Minoshima KA Frey NL Foster MR Kilbourn RA Koeppe 2000 Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex Ann Neurol 48 3 391 395 10.1002/1531-8249(200009)48:3<391::AID-ANA17>3.0.CO;2-H 1:CAS:528:DC%2BD3cXms1Ohsbc%3D 10976649 (Pubitemid 30677874)